EVALUATION OF RECOVERY TIME AND ADVERSE REACTIONS IN ATHLETES UNDERGOING PAINLESS GASTROENTEROSCOPY WITH CYCLOPROFENOL INJECTION

Abstract

Objective: To assess the recovery dynamics and adverse reactions in athletes treated with cyclopofol injection following painless gastroenteroscopy. Methods: This study included 100 athletes who underwent painless gastroenteroscopy from January to May 2023, divided into an observation group (50 athletes) receiving sufentanil with cyclopofol and a control group (50 athletes) treated with sufentanil and propofol. We measured anesthesia efficacy, recovery times, hemodynamic changes at specified intervals (before anesthesia, before the examination, during gastroenteroscopy, at the end of the procedure, and during recovery), and adverse effects. Results: The observation group used a lower total dosage of cyclopofol compared to propofol in the control group, exhibited quicker wake-up and recovery room discharge times, and achieved higher Steward recovery scores (P < 0.05). Hemodynamic measurements (MAP) at various points were significantly higher in the observation group during the procedure (P < 0.05), indicating more stable blood pressure levels. Heart rate (HR) changes showed no significant intergroup differences at any time point (P > 0.05). Adverse reactions such as injection pain, respiratory depression, and hypoxemia were lower in the cyclopofol group, although incidences of choking were slightly higher (P < 0.05). Conclusion: Cyclopofol offers superior anesthetic and recovery profiles for athletes undergoing painless gastroenteroscopy, influencing hemodynamics less and reducing adverse reactions significantly. It is recommended for clinical use in sports health management to ensure rapid recovery and minimal discomfort during invasive diagnostic procedures.